DE BERNARD, MARINA
 Distribuzione geografica
Continente #
NA - Nord America 7.759
EU - Europa 1.097
AS - Asia 751
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 9.613
Nazione #
US - Stati Uniti d'America 7.641
CN - Cina 462
IT - Italia 291
SG - Singapore 222
DE - Germania 220
GB - Regno Unito 194
FI - Finlandia 145
CA - Canada 118
SE - Svezia 101
UA - Ucraina 73
FR - Francia 46
VN - Vietnam 32
HK - Hong Kong 13
IN - India 11
ES - Italia 9
IE - Irlanda 7
JP - Giappone 5
PL - Polonia 4
NL - Olanda 3
AU - Australia 2
EU - Europa 2
BG - Bulgaria 1
BR - Brasile 1
DZ - Algeria 1
GR - Grecia 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
TR - Turchia 1
Totale 9.613
Città #
Fairfield 1.187
Woodbridge 748
Ashburn 707
Chandler 700
Ann Arbor 546
Houston 493
Seattle 413
Jacksonville 392
Cambridge 385
Wilmington 382
Princeton 174
Singapore 166
Padova 158
Boardman 153
San Diego 125
Munich 122
Beijing 112
Mcallen 109
Montréal 109
Des Moines 98
Santa Clara 87
Roxbury 76
Nanjing 74
Helsinki 51
Medford 46
Dong Ket 32
New York 30
Shenyang 30
Hebei 24
Norwalk 21
Nanchang 19
Changsha 17
Jinan 17
Milan 15
Hefei 14
Jiaxing 14
Kunming 14
Hong Kong 13
London 13
Guangzhou 11
Falls Church 10
Tianjin 10
Dublin 7
Hounslow 6
Arzignano 5
Borås 5
Indiana 5
Kharkiv 5
Kilburn 5
Ogden 5
Phoenix 5
Rockville 5
Shanghai 5
Washington 5
Agordo 4
Florence 4
Gdansk 4
Hangzhou 4
Islington 4
Ottawa 4
Redwood City 4
Rome 4
Umeå 4
Valencia 4
Venice 4
Zhengzhou 4
Buffalo 3
Detroit 3
Fuzhou 3
Haikou 3
Legnaro 3
Los Angeles 3
Ningbo 3
Taizhou 3
Tappahannock 3
Acton 2
Augusta 2
Chengdu 2
Chicago 2
Chongqing 2
Cinisello Balsamo 2
Columbus 2
Council Bluffs 2
Frankfurt am Main 2
Genoa 2
Groningen 2
Hanover 2
Matsudo 2
Mestre 2
Modena 2
New Bedfont 2
Newmarket 2
Pavia 2
Pioltello 2
Prescot 2
Taiyuan 2
Tokyo 2
Toronto 2
Trier 2
Wuhan 2
Totale 8.105
Nome #
Simulating Inflammation in a Wound Microenvironment Using a Dermal Wound-on-a-Chip Model 558
Helicobacter pylori vacuolating cytotoxin: cell intoxication and anion-specific channel activity 357
A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: an application for bladder cancer treatment 186
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. 170
Autoimmune gastritis: histology phenotype and OLGA staging. 155
Supercritical carbon dioxide combined with high power ultrasound as innovate drying process for chicken breast 146
vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity 136
The Helicobacter pylori VacA cytotoxin activates RBL-2H3 cells by inducing cytosolic calcium oscillations 133
The immune receptor CD300e negatively regulates T cell activation by impairing the STAT1-dependent antigen presentation 132
The lipoprotein HP1454 of Helicobacter pylori regulates T-cell response by shaping T-cell receptor signalling 131
A Helicobacter pylori vacuolating toxin mutant that fails to oligomerize has a dominant negative phenotype 125
TpF1 from Treponema pallidum Activates Inflammasome and Promotes the Development of Regulatory T Cells 123
The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo 123
Toll-like receptors hit calcium. 122
Structure and immunomodulatory property relationship in NapA of Borrelia burgdorferi 118
Helicobacter pylori-derived neutrophil-activating protein increases the lifespan of monocytes and neutrophils 116
3D imaging of the 58 kDa cell binding subunit of the Helicobacter pylori cytotoxin 116
The Vibrio cholerae cytolysin promotes chloride secretion from intact human intestinal mucosa. 116
Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis 116
Helicobacter pylori, asthma and allergy 114
The Helicobacter cinaedi antigen CAIP participates in atherosclerotic inflammation by promoting the differentiation of macrophages in foam cells 114
HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. 112
Glibenclamide stimulates fluid secretion in rodent cholangiocytes through a cystic fibrosis transmembrane conductance regulator-independent mechanism. 110
The concerted action of the Helicobacter pylori cytotoxin VacA and of the v-ATPase proton pump induces swelling of isolated endosomes 110
The Vibrio cholerae cytolysin promotes activation of mast cell (T helper 2) cytokine production 109
Borrelia burgdorferi NapA-Driven Th17 Cell Inflammation in Lyme Arthritis 108
The multiple cellular activities of the VacA cytotoxin of Helicobacter pylori 108
Endosome-mitochondria juxtaposition during apoptosis induced by H. pylori VacA. 107
Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies 107
Helicobacter pylori affects the antigen presentation activity of macrophages modulating the expression of the immune receptor CD300E through miR-4270 107
Helicobacter pylori Dampens HLA-II Expression on Macrophages via the Up-Regulation of miRNAs Targeting CIITA 106
[Therapy for non-muscle invasive bladder cancer: HP-NAP.] 105
Reply to letter by Nardelli and Schell commenting on the pathogenesis of Lyme arthritis 104
HP-NAP new therapy for bladder cancer: numquam periculum sine periculo vincitur 104
Bacterial toxins with intracellular protease activity 103
Cytokine BAFF Released by Helicobacter pylori-Infected Macrophages Triggers the Th17 Response in Human Chronic Gastritis. 103
Cell vacuolization induced by Helicobacter pylori VacA cytotoxin does not depend on late endosomal SNAREs 102
MicroRNA expression profiling in human Barrett's carcinogenesis. 102
The Neutrophil activating protein of Helicobacter pylori promotes T helper type 1 immune responses 101
Cell vacuolization induced by Helicobacter pylori: Inhibition by bafilomycins A1, B1, C1 and D 101
The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells 99
Treponema pallidum (syphilis) antigen TpF1 induces angiogenesis through the activation of the IL-8 pathway 99
Cell vacuolization induced by Helicobacter pylori VacA toxin: cell line sensitivity and quantitative estimation 94
CELLULAR VACUOLES INDUCED BY HELICOBACTER-PYLORI ORIGINATE FROM LATE ENDOSOMAL COMPARTMENTS 93
The effect of Helicobacter pylori on asthma and allergy 93
BAFILOMYCIN-A1 INHIBITS HELICOBACTER-PYLORI-INDUCED VACUOLIZATION OF HELA-CELLS 92
Evaluation of the efficacy of the H. Pylori protein HP-NAP as a therapeutic tool for treatment of bladder cancer in an orthotopic murine model 92
Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism. 92
Virulence factors of Helicobacter pylori 91
Characterisation of a monoclonal antibody and its use to purify the cytotoxin of Helicobacter pylori 88
The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma 87
Stimulation of TH1 response by Helicobacter pylori neutrophil activating protein decreases the protective role of IgE and eosinophils in experimental trichinellosis. 87
Cerebrospinal fluid T-regulatory cells recognize Borrelia burgdorferi NAPA in chronic Lyme borreliosis. 87
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis 85
Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells 83
The vacuolar ATPase proton pump is present on intracellular vacuoles induced by Helicobacter pylori 81
the VacA toxin of Helicobacter pylori identifies a new intermediate filament-interacting protein 81
Supercritical CO2 drying of food matrices 81
Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori 80
The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity 80
The immune modulating activity of the Helicobacter pylori HP-NAP: Friend or foe? 78
Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol 78
Tumor Cells and the Extracellular Matrix Dictate the Pro-Tumoral Profile of Macrophages in CRC 77
The small GTP binding protein rab7 is essential for cellular vacuolation induced by Helicobacter pylori cytotoxin 75
IFN-gamma and R-848 dependent activation of human monocyte-derived dendritic cells by Neisseria meningitidis adhesin A. 75
Helicobacter pylori HP0175 promotes the production of IL-23, IL-6, IL-1 beta and TGF-beta 74
Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: Possible implications for the mechanism of cellular vacuolation 74
Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin 68
Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by NapA 67
The Vibrio choleare haemolysin anion channel is required for cell vacuolation and death 67
An intracellular target for Helicobacter pylori vacuolating toxin - Response from de Bernard and Arico 64
Action site and cellular effects of cytotoxin VacA produced by Helicobacter pylori 63
VacA and HP-NAP Ying and Yang of Helicobacter pylori-associated gastric inflammation 62
Helicobacter pylori antigenic Lpp20 is a structural homologue of Tipα and promotes epithelial-mesenchymal transition 62
Molecular and Cellular Mechanisms of action of the VacA and HP-NAP virulence factors 61
Macrophage-Mediated Melanoma Reduction after HP-NAP Treatment in a Zebrafish Xenograft Model 59
Immunosuppression of T(H)2 responses in Trichinelia spiralis infection by Helicobacter pylori neutrophil-activating protein 58
Identification of Bacterial Factors Able to Promote a Th17 Response in Gastric Mucosa of H. pylori-Infected Patients 56
The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent 56
HELICOBACTER-PYLORI CYTOTOXIN - IMPORTANCE OF NATIVE CONFORMATION FOR INDUCTION OF NEUTRALIZING ANTIBODIES 56
The acid activation of Helicobacter pylori toxin VacA: Structural and membrane binding studies 55
BAFfling autoimmune disorders and helicobacter pylori disease: The interplay between BAFF and the Th17 response 55
The C2 fragment from Neisseria meningitidis antigen NHBA increases endothelial permeability by destabilizing adherens junctions. 54
Supercritical CO2 drying of food matrices 54
Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol 53
Chloride secretion in intact human colon induced by the Vibrio cholerae cytolysin 51
ADP-heptose enables Helicobacter pylori to exploit macrophages as a survival niche by suppressing antigen-presenting HLA-II expression 51
Evaluation of the ability of Helicobacter pylori in inducing the production of B cells activating factors: possible implications in the development of MALT lymphomas 50
pH responsive liposomes for enhanced local protein delivery to cancer tissues. 49
Molecular and cellular activities of Helicobacter pylori pathogenic factors 48
The Vibrio cholerae cytolysin (VCC) promotes intestinal chloride secretion and TH2 cytokines production by mucosal mast cells 48
Pathogenesis of Helicobacter pylori infection. 48
Helicobacter pylori vacuolating cytotoxin and neutrophil activating protein 47
Molecular and cellular mechanisms of action of the VacA and HP-NAP virulence factors of Helicobacter pylori 46
Immunosoppressive and Proinflammatory Activities of the VacA Toxin of Helicobacter pylori 44
INVOLVEMENT AND SOURCE OF B-CELLS ACTIVATING FACTOR(S) IN H. PYLORI-ASSOCIATED DISEASES 43
TPA and butyrate increase cell sensitivity to the vacuolating toxin of Helicobacter pylori 43
Helicobacter pylori vacuolating cytotoxin and associated pathogenic factors 42
Low pH Activates the Vacuolating Toxin of Helicobacter Pylori which Becomes Acid and Pepsin Resistant 42
To treat or not to treat Helicobacter pylori to benefit asthma patients 40
Totale 9.474
Categoria #
all - tutte 35.199
article - articoli 32.623
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 832
Totale 68.654


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.423 0 0 0 0 233 160 242 215 182 213 102 76
2020/20211.432 49 96 35 88 210 68 14 171 202 162 189 148
2021/20221.524 51 184 178 117 62 103 76 170 73 30 159 321
2022/20231.265 236 165 50 146 178 194 1 83 144 9 46 13
2023/2024813 31 94 83 51 39 61 25 262 25 25 64 53
2024/2025573 5 133 91 88 256 0 0 0 0 0 0 0
Totale 9.843